| 000 | 01462 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512053706.0 | ||
| 264 | 0 | _c19860724 | |
| 008 | 198607s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/17.suppl_b.111 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLauwers, S | |
| 245 | 0 | 0 |
_aEfficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cApr 1986 |
||
| 300 |
_a111-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacteria _xdrug effects |
| 650 | 0 | 4 |
_aBacterial Infections _xcomplications |
| 650 | 0 | 4 |
_aBronchopneumonia _xcomplications |
| 650 | 0 | 4 |
_aCholangitis _xcomplications |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntensive Care Units |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNorfloxacin _xanalogs & derivatives |
| 650 | 0 | 4 | _aPefloxacin |
| 650 | 0 | 4 |
_aPneumonia _xcomplications |
| 700 | 1 | _aVincken, W | |
| 700 | 1 | _aNaessens, A | |
| 700 | 1 | _aPierard, D | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 17 Suppl B _gp. 111-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/17.suppl_b.111 _zAvailable from publisher's website |
| 999 |
_c3464428 _d3464428 |
||